NEUROBIOGEN prioritizes its research and development efforts to develop innovative new medicine to treat patients who suffer from degenerative brain diseases and central nervous system diseases. By developing innovative drugs through the efficacy verification and clinical progress of our new drug candidates (KDS2010/SeReMABI), we will continue our journey to a global company to contribute to human health after all.